Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
1-Year Return
23.83%
This Quarter Return
+8.62%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$46.5B
AUM Growth
+$2.42B
(+5.5%)
Cap. Flow
-$465M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
22.88%
Holding
1,939
New
86
Increased
672
Reduced
507
Closed
115
Top Buys
| 1 |
Tesla
TSLA
|
+$121M |
| 2 |
Bank of America
BAC
|
+$89.3M |
| 3 |
Goldman Sachs
GS
|
+$78.4M |
| 4 |
ConocoPhillips
COP
|
+$76.4M |
| 5 |
General Motors
GM
|
+$63.9M |
Top Sells
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$261M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$148M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$101M |
| 4 |
L3Harris
LHX
|
+$74.3M |
| 5 |
Royal Bank of Canada
RY
|
+$64.9M |
Sector Composition
| 1 | Technology | 22.71% |
| 2 | Financials | 15.4% |
| 3 | Healthcare | 14.79% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Openlane
KAR
$3.12B
| $1.21M | ﹤0.01% |
80,400
-32,812
| -29% | -$492K |
|
|
LABP
1352
DELISTED
Landos Biopharma, Inc. Common Stock
LABP
| $1.2M | ﹤0.01% |
+12,500
| New | +$1.2M |
|
1353
Encore Capital Group
ECPG
$993M
| $1.2M | ﹤0.01% |
29,903
| – | – |
|
1354
Green Plains
GPRE
$635M
| $1.2M | ﹤0.01% |
44,400
| – | – |
|
1355
NOV
NOV
$4.85B
| $1.2M | ﹤0.01% |
87,432
-6,565
| -7% | -$90.1K |
|
1356
Buckle
BKE
$3.06B
| $1.2M | ﹤0.01% |
30,417
| – | – |
|
1357
Banc of California
BANC
$2.65B
| $1.19M | ﹤0.01% |
65,821
| – | – |
|
1358
Interparfums
IPAR
$3.47B
| $1.19M | ﹤0.01% |
16,735
| – | – |
|
1359
SITE Centers
SITC
$468M
| $1.19M | ﹤0.01% |
112,153
+42,298
| +61% | +$448K |
|
1360
E.W. Scripps
SSP
$246M
| $1.18M | ﹤0.01% |
61,454
| – | – |
|
1361
Triumph Financial, Inc.
TFIN
$1.42B
| $1.18M | ﹤0.01% |
15,300
+2,200
| +17% | +$170K |
|
1362
SM Energy
SM
$3.14B
| $1.18M | ﹤0.01% |
+72,100
| New | +$1.18M |
|
|
MTOR
1363
DELISTED
MERITOR, Inc.
MTOR
| $1.18M | ﹤0.01% |
40,000
| – | – |
|
1364
Enviri
NVRI
$959M
| $1.18M | ﹤0.01% |
68,554
| – | – |
|
1365
News Corp Class B
NWS
$17.8B
| $1.18M | ﹤0.01% |
50,097
-6,985
| -12% | -$164K |
|
1366
ePlus
PLUS
$1.93B
| $1.17M | ﹤0.01% |
23,570
| – | – |
|
1367
Unisys
UIS
$276M
| $1.17M | ﹤0.01% |
46,200
+4,100
| +10% | +$104K |
|
1368
Palomar
PLMR
$3.18B
| $1.17M | ﹤0.01% |
17,500
+1,000
| +6% | +$67K |
|
1369
Addus HomeCare
ADUS
$2.03B
| $1.17M | ﹤0.01% |
11,200
| – | – |
|
1370
Iovance Biotherapeutics
IOVA
$861M
| $1.17M | ﹤0.01% |
36,905
-1,460
| -4% | -$46.2K |
|
1371
Bio-Rad Laboratories Class A
BIO
$7.49B
| $1.17M | ﹤0.01% |
2,040
-284
| -12% | -$162K |
|
1372
Flowserve
FLS
$7.35B
| $1.16M | ﹤0.01% |
30,000
+4,051
| +16% | +$157K |
|
|
KRA
1373
DELISTED
Kraton Corporation
KRA
| $1.16M | ﹤0.01% |
31,803
| – | – |
|
1374
Atmos Energy
ATO
$26.3B
| $1.16M | ﹤0.01% |
11,710
-36,809
| -76% | -$3.64M |
|
1375
Usana Health Sciences
USNA
$551M
| $1.14M | ﹤0.01% |
11,700
+600
| +5% | +$58.6K |
|